Several other weight-loss pills are also in late-stage trials, and if all goes smoothly, could be approved in the next few years. They include one called orforglipron, which also mimics GLP-1, and an ...
Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established drugmakers and an emerging market of compounded versions as telehealth ...
The future of oral weight loss medication looks bright. Drug manufacturer Novo Nordisk announced a new experimental ...
That Ozempic (or Wegovy, the name by which the weight-loss version of the drug semaglutide is marketed) should have proliferated in an industry that has always venerated thinness will hardly come as a ...
To date, a number of clinical trials have shown weight regain after discontinuing GLP-1 drugs. In the STEP 1 trial extension, ...
Some counterfeits contain bacteria and have high impurity levels or different chemical structures to FDA-approved medicines.
A key study used in securing FDA approval for Wegovy as a lifetime medication for weight loss was based on patients using the ...
Physicians fear use of weight loss drugs in teens will increase or exacerbate eating disorder cases, adding complexity to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback